Informace o publikaci

Erythropoetins in Therapy from the Point of View of a Medicinal Chemist


FARSA Oldřich ZUBÁČ Peter

Rok publikování 2019
Druh Článek v odborném periodiku
Časopis / Zdroj CHEMICKÉ LISTY
Fakulta / Pracoviště MU

Farmaceutická fakulta

www Stránky časopisu Chemické listy
Klíčová slova biological therapeutics; haematopoietic factors; erythropoietin
Popis Hematopoietic growth factors are cytokines which stimulate growth of hematopoietic pluripotent stem cells and their differentiation and maturation into fully functional blood cells, either erythrocytes or various types of white blood cells. Erythropoietin is a glycosylated peptide hormone which stimulates production of red blood cells. It is used for treatment of anaemia caused by a chronic kidney failure. For therapeutic purposes, it is produced by recombinant technologies predominantly using modified mammalian cells. This procedure leads, however, to peptides of the same sequence of 165 amino acids but with different glycosylation patterns. These different mixtures of erythropoietin glycoforms have been designated with different INN names epoetin alfa - omega. Peginesatid (Omontys (R)) is a synthetic erythropoietin receptor agonist, the structure of which does not match that of erythropoietin. It is a pegylated covalent dimer of two identical peptide chains. It has been abandoned due to an increased mortality from cardiovascular reasons and due to dangerous allergies.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info